USTR considers tariffs on Germany over drug pricing
The Office of the US Trade Representative Tuesday juggled how to respond to Germany’s drug pricing practices as industry officials and experts largely blamed the country for suppressing prices that they...To view the full article, register now.
Already a subscriber? Click here to view full article